查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2017180

内视镜手术器材市场：依器材类型、应用、操作模式及最终用户划分－2026-2032年全球市场预测

Endosurgery Device Market by Device Type, Application, Operation Mode, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，内视镜手术器械市场价值将达到 348.3 亿美元，到 2026 年将成长至 366.3 亿美元，到 2032 年将达到 531.2 亿美元，复合年增长率为 6.21%。

主要市场统计数据
基准年 2025 348.3亿美元
预计年份：2026年 366.3亿美元
预测年份 2032 531.2亿美元
复合年增长率 (%) 6.21%

本次演讲清晰权威地概述了当前影响整个医疗保健系统内视镜手术器械策略的临床、技术和营运趋势。

内视镜手术器材市场目前正处于转型期，技术日趋成熟、临床重点不断变化以及手术诊疗流程中操作规范的演变交织在一起。本文概述了微创手术器械的竞争格局和临床应用，重点在于视觉化、能量传输、入路工具和辅助耗材之间的相互作用。此外，本文也着重阐述了光学、电子机械和整合系统领域的进步如何改变手术流程和临床医师的选择偏好。

技术进步、监管预期和供应链韧性如何融合，重新定义内视镜外科医疗设备的价值创造。

在内镜外科领域，一场变革正在发生，它正在重塑价值创造的结构以及相关人员获取价值的方式。首先，可视化和成像技术的进步不再局限于渐进式改进，而是为手术提供了多方面的见解。高清光学元件和整合式摄影机系统提高了组织识别的准确性，结合影像校正和人工智慧辅助的迭加功能，它们缩短了掌握复杂微创手术技术所需的时间。这一趋势正在推动对内视镜及相关视觉化平台的投资，这些平台能够与数位化手术室生态系统无缝整合。

评估 2025 年美国关税调整将如何影响内视镜手术器械的筹资策略、采购实务和商业化时间表。

美国2025年实施的关税政策已成为内视镜手术器械国际供应商和国内买家必须考虑的关键营运因素。具体影响包括：需要更加重视供应链规划、合约重新谈判以及采购柔软性。与依赖单一离岸供应链的公司相比，拥有垂直整合业务结构和近岸生产能力的製造商更有能力应对不断上涨的成本压力。

将医疗设备分类、临床专科、医疗机构和营运模式与其各自的采用和采购趋势连结起来的综合細項分析。

精细的市场细分技术揭示了每种医疗设备类型、临床应用、最终用户和操作模式的不同采用模式、报销考量和采购因素。基于器械类型，市场分析检验了内视镜和视觉化系统、能量器械、供气设备、腹腔镜器械、组织粉碎器和组织取回袋。内视镜和视觉化系统进一步细分为摄影系统、软式内视镜和硬式内视镜，而能量器材则进一步分为电外科器材、雷射器材和超音波器材。这些分类至关重要，因为每个子类别都遵循不同的创新週期和临床医生采用过程。

在全球内视镜手术市场中，医疗保健系统、采购实务和製造趋势的区域差异如何塑造差异化的打入市场策略。

区域趋势对全球内视镜手术市场的产品策略、监管应对方案和商业性重点有显着影响。在美洲，人们越来越重视能够证明临床路径中运作效率、手术处理能力和治疗效果均有所提升的证据。这促使人们对能够缩短手术时间和降低併发症率的整合式视觉化平台和节能设备产生了浓厚的兴趣。此外，这些市场中支付方的严格审查和医院整合也推动了对强有力的成本效益论点和可跨多个临床科室部署的多功能产品系列的需求。

在采购内视镜手术设备时，对竞争定位、伙伴关係模式和商业策略的评估决定了哪些公司能够获得长期合约。

内视镜手术器材领域的竞争格局由成熟的平台供应商、专注于特定领域的创新企业以及新兴的区域性製造商组成。成熟企业持续投资于平台整合、系统互通性和广泛的临床研究，以保持其在关键器材类别中的领先地位。同时，专注于特定领域的创新企业也在推动技术进步，例如超音波发生器和一次性器材创新。

针对整个内视镜手术器材产品组合，制定製造商和医疗保健提供者的具体策略重点，以加速产品采用、提高韧性并创造价值。

产业领导者必须采取一系列切实可行的优先事项，将新机会转化为可持续的竞争优势。首先，投资于临床证据项目，将医疗设备的使用与治疗效果的显着改善和工作流程的最佳化联繫起来，从而为医院和门诊采购负责人构建引人注目的价值提案。其次，实现製造地多元化，并对关键零件的替代供应商进行认证，以降低贸易政策变更和供应链中断带来的风险。

采用透明的混合方法研究途径，结合临床医师的见解、监管记录、临床文献和供应链分析，得出可靠的结论。

本研究采用混合方法进行综合分析，结合了对临床医生、采购经理和行业高管的访谈，以及对监管文件、临床文献和公开资讯的二次分析。访谈提供了有关医疗设备可用性、临床偏好和采购行为的背景信息，而二次资讯则用于检验监管时间表、医疗设备核准情况和技术扩散趋势。

为了维持内视镜手术器材的长期相关性，我们需要整合将技术潜力、临床有效性和营运弹性连结起来的策略挑战。

总之，内视镜手术器材市场格局复杂，但也蕴藏着许多机会，这主要得益于可视化技术的进步、能量模式的多样化以及人们对一次性使用和互通性需求的不断变化。能够将产品创新与可证实的临床效益、灵活的经营模式和稳健的供应链相结合的製造商，将更有利于加速产品在所有医疗机构中的普及应用。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 内视镜手术器械市场：依器械类型划分

  • 内视镜和视觉化系统
    • 网路摄影系统
    • 软式内视镜
    • 硬式内视镜
  • 能源设备
    • 电外科设备
    • 雷射设备
    • 超音波设备
  • 供气设备
  • 腹腔镜器械
  • 碎切器
  • 纸巾收集袋

第九章 内视镜手术器械市场：依应用领域划分

  • 循环系统
  • 耳鼻喉科
  • 一般外科
  • 妇科
  • 泌尿系统

第十章 内视镜手术器械市场（依用途划分）

  • 一次性的
  • 可重复使用的

第十一章 内视镜手术器械市场：依最终用户划分

  • 门诊手术中心
  • 医院
  • 专科诊所

第十二章 内视镜手术器械市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 内视镜手术器材市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 内视镜手术器械市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国内视镜手术器械市场

第十六章：中国内窥镜手术器材市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • ConMed Corporation
  • Hologic, Inc.
  • Intuitive Surgical, Inc.
  • Johnson & Johnson
  • KARL STORZ SE & Co. KG
  • Medtronic plc
  • Olympus Corporation
  • Smith & Nephew plc
  • Stryker Corporation
Product Code: MRR-0355054AC519

The Endosurgery Device Market was valued at USD 34.83 billion in 2025 and is projected to grow to USD 36.63 billion in 2026, with a CAGR of 6.21%, reaching USD 53.12 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 34.83 billion
Estimated Year [2026] USD 36.63 billion
Forecast Year [2032] USD 53.12 billion
CAGR (%) 6.21%

A clear and authoritative framing of current clinical, technological, and operational trends shaping endosurgery device strategies across healthcare systems

The endosurgery device landscape is undergoing a convergent period of technological refinement, shifting clinical priorities, and evolving operational expectations within surgical care pathways. This introduction frames the competitive and clinical context for devices that enable minimally invasive procedures, highlighting the interplay between visualization, energy delivery, access tools, and adjunctive consumables. It emphasizes how advances in optics, electromechanics, and integrated systems are altering procedural workflows and clinician preferences.

Clinicians and hospital administrators are increasingly prioritizing devices and platforms that deliver reproducible outcomes, reduce perioperative variability, and support throughput in constrained surgical schedules. Consequently, device manufacturers are investing in improved camera systems, ergonomics for laparoscopy, and energy modalities that offer controlled tissue effect while minimizing collateral damage. At the same time, payers and procurement leaders are scrutinizing lifecycle costs and reprocessing burdens, which influences the balance between disposable and reusable operation modes.

This introduction sets the scene for a deeper exploration of transformative shifts, tariff impacts, segmentation nuance, regional dynamics, corporate strategy, and pragmatic recommendations. It prepares readers to interpret how clinical needs, regulatory expectations, and supply chain pressures combine to shape strategic choices across product development, market entry, and commercialization pathways.

How converging technological advances, regulatory expectations, and supply chain resilience are collectively redefining value creation in endosurgery devices

The endosurgery field is experiencing transformative shifts that are reshaping where value is created and how stakeholders capture it. First, visualization and imaging advances are moving beyond incremental improvements to deliver multimodal intraoperative insight. High-definition optics and integrated camera systems are enabling more precise tissue identification, and when combined with image enhancement and AI-enabled overlays, they are facilitating shorter learning curves for complex minimally invasive techniques. This trend is catalyzing investment in endoscopes and adjacent visualization platforms that integrate seamlessly with digital operating room ecosystems.

Second, diversification of energy platforms is expanding clinical options for hemostasis and tissue dissection. Electrosurgical devices remain a workhorse in many procedures, while laser and ultrasonic modalities increasingly address niche indications where their distinct tissue interaction profiles offer clinical advantages. As clinicians adopt these modalities, manufacturers must provide clear comparative evidence on safety, efficacy, and ease of use to support substitution or complementary use.

Third, the balance between disposable and reusable operation modes is shifting as hospitals weigh infection control, environmental impact, and total cost of ownership. Disposable instruments reduce reprocessing risk and turnover time, whereas reusable systems can lower per-procedure device spend if reprocessing infrastructure is optimized. This dynamic is driving hybrid solutions and modular designs that allow selective disposability of high-risk components.

Fourth, regulatory rigor and supply chain resilience have moved to the forefront in response to prior disruptions. Manufacturers are redesigning sourcing strategies, increasing component redundancy, and engaging earlier with regulators to expedite approvals while maintaining compliance. These structural changes are altering time-to-market calculations and emphasizing quality management systems as a competitive differentiator.

Collectively, these shifts are not isolated; they interact to influence product roadmaps, clinical adoption strategies, and procurement decisions. The net result is a market environment where agility, evidence generation, and cross-functional collaboration determine which technologies transition from niche tools to standard-of-care platforms.

Assessment of how 2025 United States tariff adjustments are influencing sourcing strategies, procurement behavior, and commercialization timelines across endosurgery devices

Tariff policy introduced in 2025 in the United States has surfaced as a meaningful operational consideration for international suppliers and domestic purchasers of endosurgery devices. The tangible effect has been a heightened focus on supply chain mapping, contract renegotiation, and sourcing flexibility. Manufacturers with vertically integrated operations or nearshore production capabilities have been positioned to mitigate incremental cost pressures more effectively than firms reliant on a single offshore supply base.

Operations teams have responded by accelerating localization of critical components and qualifying alternative suppliers to reduce exposure to tariff-induced cost volatility. Procurement organizations have revisited legacy agreements to shift more of the total landed cost calculus into forward-looking pricing models that account for duties, freight variability, and inventory carrying costs. These actions have prompted a wave of commercial discussions around adjusted pricing frameworks and longer-term supply commitments.

Clinically, the tariff environment has sometimes delayed scheduled technology rollouts or forced phased introductions where hospitals prioritized capital investments with clearer near-term return on investment. Meanwhile, regulatory and contracting teams have had to reconcile product labeling, customs classification, and documentation to avoid inadvertent duty escalation. From an innovation perspective, tariff-related pressures have encouraged partnerships and licensing arrangements that preserve access to advanced features without necessitating full-scale manufacturing relocations.

In summary, the tariff landscape in 2025 has reinforced the importance of flexible manufacturing footprints, transparent cost-to-serve models, and collaborative commercial strategies. Stakeholders that proactively assess duty exposure, diversify supply chains, and align commercial terms with supply realities are better positioned to sustain adoption momentum despite the headwinds introduced by new trade measures.

Comprehensive segmentation interpretation linking device classes, clinical specialties, care settings, and operation modes to distinct adoption and procurement dynamics

A nuanced segmentation approach illuminates divergent adoption patterns, reimbursement considerations, and procurement drivers across device types, clinical applications, end users, and operation modes. Based on Device Type, market analysis examines Endoscopes And Visualization Systems, Energy Devices, Insufflators, Laparoscopic Instruments, Morcellators, and Tissue Retrieval Bags, with Endoscopes And Visualization Systems further parsed into Camera Systems, Flexible Endoscopes, and Rigid Endoscopes, and Energy Devices further explored across Electrosurgical Devices, Laser Devices, and Ultrasonic Devices; these distinctions matter because each subgroup follows different innovation cycles and clinician acceptance pathways.

Based on Application, the study spans Cardiovascular, ENT, General Surgery, Gynecology, and Urology, reflecting how procedural volumes, anatomical complexity, and clinical outcome priorities diverge across specialties and thereby influence device selection. Based on End User, attention is given to Ambulatory Surgical Centers, Hospitals, and Specialty Clinics, as procurement policies, capital expenditure thresholds, and throughput objectives vary considerably between these settings, shaping which devices become preferred. Based on Operation Mode, the disposable versus reusable dichotomy is examined as a strategic axis that affects manufacturing decisions, sterilization workflows, and environmental considerations.

Interpreting these segmentation dimensions together reveals patterns that single-axis analyses miss. For example, rigid endoscopes continue to be predominant in certain ENT procedures where durability and optics are paramount, while flexible endoscopes and advanced camera systems are gaining traction in general surgery and urology due to their maneuverability and visualization advantages. Electrosurgical devices remain widely adopted across specialties because of their versatility, yet ultrasonic and laser systems are carving out niches in procedures where tissue selectivity and reduced thermal spread are decisive. Ambulatory surgical centers show faster uptake of compact, plug-and-play systems that minimize turnover time, whereas large hospitals prioritize integrated platforms that dovetail with enterprise-wide digital health strategies. Finally, the disposable versus reusable calculus is influenced by both clinical risk tolerance and institutional capacity for reprocessing, which can differ markedly between specialty clinics and tertiary hospitals.

These segmentation insights provide a roadmap for aligning product development, clinical evidence generation, and commercial engagement with the distinct requirements of each device subclass, application area, and care setting.

How distinct regional healthcare structures, procurement behaviors, and manufacturing trends are shaping differentiated go-to-market strategies across global endosurgery landscapes

Regional dynamics exert a powerful influence on product strategy, regulatory planning, and commercial prioritization across global endosurgery markets. In the Americas, clinical pathways emphasize operational efficiency, procedural throughput, and evidence demonstrating improved outcomes; this has prompted strong interest in integrated visualization platforms and energy devices that reduce operative time and complication rates. Payer scrutiny and hospital consolidation in these markets also demand robust cost-effectiveness narratives and versatile product portfolios that can be deployed across multiple service lines.

In Europe, Middle East & Africa, health systems present a heterogeneous mix of centralized procurement, national regulatory frameworks, and variable infrastructure maturity. Western European markets often prioritize interoperability with existing hospital systems and adherence to stringent regulatory standards, while emerging markets within the region demonstrate demand for cost-effective, robust devices that can perform reliably in resource-constrained settings. Middle Eastern and African buyers may value supplier responsiveness and aftermarket service capabilities in addition to baseline clinical performance.

Asia-Pacific markets exhibit rapid clinical adoption in certain urban centers, strong investment in surgical capacity expansion, and a growing domestic manufacturing base. These dynamics create both opportunity and competition for international suppliers, as regional OEMs increasingly offer localized alternatives. Moreover, regulatory pathways in several Asia-Pacific countries are evolving to accelerate access to innovative surgical technologies, which necessitates tailored regulatory strategies and local clinical validation to support adoption.

Taken together, these regional characteristics require manufacturers to calibrate go-to-market strategies by balancing global platform consistency with local adaptation. Effective regional approaches combine clinical evidence generation, targeted reimbursement engagement, and service models that reflect the operational realities of each geography.

Evaluating competitive positioning, partnership models, and commercial tactics that determine which companies secure long-term preference in endosurgery device procurement

Competitive dynamics in the endosurgery device arena are shaped by a mix of incumbent platform providers, specialized niche innovators, and emerging regional manufacturers. Established companies continue to invest in platform consolidation, system interoperability, and broad clinical studies to maintain leadership across core device categories. At the same time, focused innovators are driving advancement in discrete areas such as advanced imaging modules, ultrasonic generators, and single-use instrument innovations.

Strategic behaviors to watch include partnership models that combine established distribution networks with technology-enabled startups to accelerate commercialization. Licensing arrangements and co-development agreements are increasingly used to access algorithmic capabilities, sensor technologies, or disposable component designs without incurring full internal R&D costs. Additionally, aftermarket service offerings and performance-based contracting are becoming more visible as companies seek to lock in long-term relationships with large hospital systems.

From an execution perspective, thin margins on commoditized consumables place a premium on operational excellence, whereas differentiated platform features allow for value-based pricing aligned with clinical outcomes. Companies that can demonstrate reproducible clinical benefits, streamlined workflows, and total cost advantages are better positioned to secure preference in procurement dialogs. Finally, corporate strategies that emphasize regulatory preparedness, supply chain redundancy, and a clear sustainability narrative will likely gain favor among institutional buyers prioritizing resilience and environmental stewardship.

Actionable strategic priorities for manufacturers and healthcare providers to accelerate adoption, improve resilience, and capture value across endosurgery device portfolios

Industry leaders must pursue a set of actionable priorities to convert emerging opportunities into sustained advantage. First, invest in clinical evidence programs that link device use to meaningful outcome improvements and workflow efficiencies, thereby creating a defensible value proposition for hospital and ambulatory buyers. Second, diversify manufacturing footprints and qualify alternate suppliers for critical components to reduce exposure to trade policy changes and supply chain interruptions.

Third, develop flexible commercial models that accommodate different purchasing mindsets across care settings; this includes offering modular platforms that support both reusable core systems and disposable adjuncts, as well as subscription or service-based contracts that align vendor incentives with clinical performance. Fourth, build interoperability and digital integration into new products to meet the growing demand for connected operating room ecosystems and to facilitate real-world data capture for post-market surveillance and optimization.

Fifth, accelerate regulatory and reimbursement engagement by preparing robust dossiers early and engaging payers with health economic evidence. Sixth, prioritize aftermarket service excellence and training programs to reduce device downtime and to shorten time-to-proficiency for clinicians adopting new technologies. By pursuing these coordinated actions, leaders can enhance adoption velocity, protect margin, and create sustainable differentiation in a competitive landscape.

Transparent mixed-methods research approach combining clinician insights, regulatory records, clinical literature, and supply chain analysis to ensure robust conclusions

This research synthesis draws on a mixed-methods approach that combines primary interviews with clinicians, procurement leaders, and industry executives with secondary analysis of regulatory filings, clinical literature, and public disclosures. Primary qualitative interviews provided context on device usability, clinical preferences, and procurement behaviors, while secondary sources were used to validate regulatory timelines, device approvals, and technology diffusion trends.

The methodological approach emphasized triangulation to reduce bias: insights from clinician interviews were compared with procurement perspectives and corroborated with product labeling and safety communications. In addition, supply chain analyses reviewed public company disclosures and trade data to map sourcing footprints and identify resilience strategies. Wherever possible, methodology prioritized recent, peer-reviewed clinical studies and device-specific safety information to ground statements about clinical impact and procedural use.

Limitations of the approach include variability in reporting standards across jurisdictions and the uneven availability of head-to-head comparative data for some emerging energy modalities. To mitigate these constraints, the research applied conservative interpretation where direct comparisons were absent and highlighted areas where further controlled clinical evaluation would be beneficial. The result is a rigorous, multi-dimensional view intended to support strategic decision-making without overreliance on any single data source.

Synthesis of strategic imperatives that bridge technological promise, clinical validation, and operational resilience to sustain long-term relevance in endosurgery devices

In conclusion, the endosurgery device landscape presents a complex but navigable set of opportunities driven by improvements in visualization, diversification of energy modalities, and evolving expectations around disposability and interoperability. Manufacturers that align product innovation with demonstrable clinical benefit, flexible commercial models, and resilient supply chains will be better positioned to influence adoption across care settings.

Regional nuance matters: success in the Americas, Europe, Middle East & Africa, and Asia-Pacific requires tailored strategies that reflect local procurement structures, regulatory pathways, and manufacturing realities. Competitive advantage will accrue to organizations that can combine clinical evidence with operational support and sustainable service models. As tariffs and trade dynamics continue to inject uncertainty, agility in sourcing and pricing strategy will remain essential.

Ultimately, the path forward demands coordinated efforts across R&D, regulatory, commercial, and operations teams to translate technological promise into clinical and economic value. Stakeholders who prioritize transparent evidence generation, customer-centric service delivery, and adaptive manufacturing will find the clearest route to long-term relevance and impact.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Endosurgery Device Market, by Device Type

  • 8.1. Endoscopes And Visualization Systems
    • 8.1.1. Camera Systems
    • 8.1.2. Flexible Endoscopes
    • 8.1.3. Rigid Endoscopes
  • 8.2. Energy Devices
    • 8.2.1. Electrosurgical Devices
    • 8.2.2. Laser Devices
    • 8.2.3. Ultrasonic Devices
  • 8.3. Insufflators
  • 8.4. Laparoscopic Instruments
  • 8.5. Morcellators
  • 8.6. Tissue Retrieval Bags

9. Endosurgery Device Market, by Application

  • 9.1. Cardiovascular
  • 9.2. ENT
  • 9.3. General Surgery
  • 9.4. Gynecology
  • 9.5. Urology

10. Endosurgery Device Market, by Operation Mode

  • 10.1. Disposable
  • 10.2. Reusable

11. Endosurgery Device Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Hospitals
  • 11.3. Specialty Clinics

12. Endosurgery Device Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Endosurgery Device Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Endosurgery Device Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Endosurgery Device Market

16. China Endosurgery Device Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. B. Braun Melsungen AG
  • 17.6. Boston Scientific Corporation
  • 17.7. ConMed Corporation
  • 17.8. Hologic, Inc.
  • 17.9. Intuitive Surgical, Inc.
  • 17.10. Johnson & Johnson
  • 17.11. KARL STORZ SE & Co. KG
  • 17.12. Medtronic plc
  • 17.13. Olympus Corporation
  • 17.14. Smith & Nephew plc
  • 17.15. Stryker Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ENDOSURGERY DEVICE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ENDOSURGERY DEVICE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY OPERATION MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES ENDOSURGERY DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA ENDOSURGERY DEVICE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY ENDOSCOPES AND VISUALIZATION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY ENDOSCOPES AND VISUALIZATION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY ENDOSCOPES AND VISUALIZATION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY ENDOSCOPES AND VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY CAMERA SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY CAMERA SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY CAMERA SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY RIGID ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY RIGID ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY RIGID ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY ENERGY DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY ENERGY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY ENERGY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY ENERGY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY ELECTROSURGICAL DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY ELECTROSURGICAL DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY ELECTROSURGICAL DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY LASER DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY LASER DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY LASER DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY ULTRASONIC DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY ULTRASONIC DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY ULTRASONIC DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY INSUFFLATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY INSUFFLATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY INSUFFLATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY LAPAROSCOPIC INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY LAPAROSCOPIC INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY LAPAROSCOPIC INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY MORCELLATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY MORCELLATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY MORCELLATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY TISSUE RETRIEVAL BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY TISSUE RETRIEVAL BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY TISSUE RETRIEVAL BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY ENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY ENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY ENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY GYNECOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY GYNECOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY GYNECOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY UROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY UROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY UROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY DISPOSABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY DISPOSABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY DISPOSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY REUSABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY REUSABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY REUSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS ENDOSURGERY DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS ENDOSURGERY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS ENDOSURGERY DEVICE MARKET SIZE, BY ENDOSCOPES AND VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS ENDOSURGERY DEVICE MARKET SIZE, BY ENERGY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS ENDOSURGERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS ENDOSURGERY DEVICE MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS ENDOSURGERY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA ENDOSURGERY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA ENDOSURGERY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA ENDOSURGERY DEVICE MARKET SIZE, BY ENDOSCOPES AND VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA ENDOSURGERY DEVICE MARKET SIZE, BY ENERGY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA ENDOSURGERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA ENDOSURGERY DEVICE MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA ENDOSURGERY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA ENDOSURGERY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA ENDOSURGERY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA ENDOSURGERY DEVICE MARKET SIZE, BY ENDOSCOPES AND VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA ENDOSURGERY DEVICE MARKET SIZE, BY ENERGY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA ENDOSURGERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA ENDOSURGERY DEVICE MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA ENDOSURGERY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA ENDOSURGERY DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA ENDOSURGERY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA ENDOSURGERY DEVICE MARKET SIZE, BY ENDOSCOPES AND VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA ENDOSURGERY DEVICE MARKET SIZE, BY ENERGY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA ENDOSURGERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA ENDOSURGERY DEVICE MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA ENDOSURGERY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE ENDOSURGERY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE ENDOSURGERY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE ENDOSURGERY DEVICE MARKET SIZE, BY ENDOSCOPES AND VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE ENDOSURGERY DEVICE MARKET SIZE, BY ENERGY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE ENDOSURGERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE ENDOSURGERY DEVICE MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE ENDOSURGERY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST ENDOSURGERY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST ENDOSURGERY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST ENDOSURGERY DEVICE MARKET SIZE, BY ENDOSCOPES AND VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST ENDOSURGERY DEVICE MARKET SIZE, BY ENERGY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST ENDOSURGERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST ENDOSURGERY DEVICE MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST ENDOSURGERY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. AFRICA ENDOSURGERY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA ENDOSURGERY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA ENDOSURGERY DEVICE MARKET SIZE, BY ENDOSCOPES AND VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA ENDOSURGERY DEVICE MARKET SIZE, BY ENERGY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA ENDOSURGERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA ENDOSURGERY DEVICE MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA ENDOSURGERY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC ENDOSURGERY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC ENDOSURGERY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC ENDOSURGERY DEVICE MARKET SIZE, BY ENDOSCOPES AND VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC ENDOSURGERY DEVICE MARKET SIZE, BY ENERGY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC ENDOSURGERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC ENDOSURGERY DEVICE MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC ENDOSURGERY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN ENDOSURGERY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. ASEAN ENDOSURGERY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. ASEAN ENDOSURGERY DEVICE MARKET SIZE, BY ENDOSCOPES AND VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN ENDOSURGERY DEVICE MARKET SIZE, BY ENERGY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN ENDOSURGERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. ASEAN ENDOSURGERY DEVICE MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN ENDOSURGERY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. GCC ENDOSURGERY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. GCC ENDOSURGERY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. GCC ENDOSURGERY DEVICE MARKET SIZE, BY ENDOSCOPES AND VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 142. GCC ENDOSURGERY DEVICE MARKET SIZE, BY ENERGY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 143. GCC ENDOSURGERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. GCC ENDOSURGERY DEVICE MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 145. GCC ENDOSURGERY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION ENDOSURGERY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPEAN UNION ENDOSURGERY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPEAN UNION ENDOSURGERY DEVICE MARKET SIZE, BY ENDOSCOPES AND VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPEAN UNION ENDOSURGERY DEVICE MARKET SIZE, BY ENERGY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPEAN UNION ENDOSURGERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION ENDOSURGERY DEVICE MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION ENDOSURGERY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 153. BRICS ENDOSURGERY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. BRICS ENDOSURGERY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. BRICS ENDOSURGERY DEVICE MARKET SIZE, BY ENDOSCOPES AND VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 156. BRICS ENDOSURGERY DEVICE MARKET SIZE, BY ENERGY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 157. BRICS ENDOSURGERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 158. BRICS ENDOSURGERY DEVICE MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 159. BRICS ENDOSURGERY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 160. G7 ENDOSURGERY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. G7 ENDOSURGERY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. G7 ENDOSURGERY DEVICE MARKET SIZE, BY ENDOSCOPES AND VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 163. G7 ENDOSURGERY DEVICE MARKET SIZE, BY ENERGY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 164. G7 ENDOSURGERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 165. G7 ENDOSURGERY DEVICE MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 166. G7 ENDOSURGERY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. NATO ENDOSURGERY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. NATO ENDOSURGERY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. NATO ENDOSURGERY DEVICE MARKET SIZE, BY ENDOSCOPES AND VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 170. NATO ENDOSURGERY DEVICE MARKET SIZE, BY ENERGY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 171. NATO ENDOSURGERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 172. NATO ENDOSURGERY DEVICE MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 173. NATO ENDOSURGERY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL ENDOSURGERY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. UNITED STATES ENDOSURGERY DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 176. UNITED STATES ENDOSURGERY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. UNITED STATES ENDOSURGERY DEVICE MARKET SIZE, BY ENDOSCOPES AND VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED STATES ENDOSURGERY DEVICE MARKET SIZE, BY ENERGY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 179. UNITED STATES ENDOSURGERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 180. UNITED STATES ENDOSURGERY DEVICE MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 181. UNITED STATES ENDOSURGERY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. CHINA ENDOSURGERY DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 183. CHINA ENDOSURGERY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. CHINA ENDOSURGERY DEVICE MARKET SIZE, BY ENDOSCOPES AND VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 185. CHINA ENDOSURGERY DEVICE MARKET SIZE, BY ENERGY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 186. CHINA ENDOSURGERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. CHINA ENDOSURGERY DEVICE MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 188. CHINA ENDOSURGERY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)